布鲁克在2026年度慕尼黑分析生化展（Analytica 2026）上展示面向应用、生物制药、工业及学术市场的分析与自动化创新成果
MUNICH, Germany – March 24, 2026 – At Analytica 2026, Bruker (Nasdaq: BRKR) highlights novel analytical systems and workflows for chemistry and life science research, applied, biopharma and industrial research and QC, including Chemspeed lab automation and SciY lab scientific and data management software.
A key biopharma highlight is the iNTApharma™ system for cell & gene therapy (CGT) applications. The new iNTApharma is a label-free platform for quantitative characterization of nanoscale bioparticles in native aqueous media. The system provides size and concentration measurements within minutes with single-particle sensitivity, without labeling or chemical modification. Optimized for particles in the 50 to 300 nanometer range, iNTApharma is suitable for extracellular vesicle (EV) research, adenoviral and lentiviral vector analysis, as well as for the analysis of lipid nanoparticles (LNP) used in nucleic-acid delivery. A built-in well-plate reader supports standard laboratory workflows, and iNTApharma can also resolve subpopulations in heterogeneous biological samples.
For chemistry laboratories, the expanded benchtop FT-NMR Fourier 80 Automation Suite supports labs processing more than 50 samples per day. The system supports 108 room-temperature positions, with options to 252 positions, plus optional cooling or heating, with barcode reading and user-defined waste handling. These permanent-magnet NMR capabilities improve throughput, repeatability, and method standardization while reducing errors and reruns in unattended batch workflows.
Bruker is launching the affordable Fourier 80 Duo to offer 80 MHz resolution and sensitivity as an accessible new standard for benchtop proton-carbon FT-NMR in chemistry labs that so far have used 60 MHz systems. The Fourier 80 Duo includes state-of-the art inverse g-¹H/¹³C capabilities with TopSpin software and gradient spectroscopy for research flexibility and analytical performance.
In applied and industrial settings, Bruker introduces TITAN, the next-generation handheld XRF analyzer for elemental analysis from magnesium to uranium. Designed for field use and production-floor environments, TITAN combines high-performance XRF with an operator-focused interface that includes smart workflows, reporting and connectivity features. The TITAN system is used in industrial QC, materials ID, and regulatory screening, where reliable, traceable elemental results are required in demanding operating conditions.
The SPR Pro8 Series of Surface Plasmon Resonance systems for biomolecular interaction analysis is available with 24 or 32 measurement spots, and up to 8 buffer conditions per run to streamline assay development and multi-condition screening. Integration with Genedata supports data management as well as consistent QC and analysis across instruments.
The Chemspeed Flex EP is an automated eluent-preparation workstation that prepares up to 16 different eluents in standard 0.5, 1 or 2 liter glass bottles with throughput of 60 to 120 liters per day. The Flex EP handles organic and aqueous solvents as well as acid/base and solid components, and integrates pH measurement and adjustment, QR-code material verification, digital documentation, and LIMS connectivity to support consistent, compliant, and traceable operation.
The SciY Digitalization Suite advances lab workflow integration, automated data management, and AI-ready data use across R&D, QC, and manufacturing through a vendor-agnostic software environment. Within SciY, the ZONTAL platform automates the capture and centralization of data across the organization, helping make lab data Findable, Accessible, Interoperable, and Reusable (FAIR). By applying a common metadata standard for instrument and analysis data and supporting enterprise ontologies, the ZONTAL platform helps to use lab R&D and QC data more effectively across AI and analytics workflows.
Bruker will exhibit at Analytica 2026, March 24–27, 2026, in Hall A2, Booth 314. For more information: www.bruker.com/en/news-and-events/events/analytica.html
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
Media Contact
Markus Ziegler
Sr. Director and Head of Group Marketing, Bruker BioSpin
T: +49 172 3733531
E: pr@bruker.com